Not Yet RecruitingPhase 4ACTRN12611001005943

Can certain anaesthesia medications & techniques provide additional benefits after cancer surgery apart from pain relief and speed of recovery from that surgery (LIPO trial - Lignocaine infusion given peri-operatively)

Can anaesthetic technique in the form of peri-operative lignocaine infusion to blunt surgical stress response have additional benefits in long term outcome following primary cancer surgery


Sponsor

Palmerston North Hospital

Enrollment

600 participants

Start Date

Oct 1, 2011

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 40 YearssMax Age: 80 Yearss

Plain Language Summary

Simplified for easier understanding

The LIPO trial investigates whether a continuous infusion of lignocaine (a local anesthetic) given during and after cancer surgery can provide benefits beyond pain relief, such as potentially affecting cancer recurrence. It includes adults aged 40 to 80 undergoing primary surgery for non-metastatic cancer (colon, kidney, prostate, uterus, melanoma, breast, or bladder).

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Intra-operative lignocaine infusion. Replica of methodology from existing study, specifically Kuo et al, British Journal of Anaesthesia, 97 (5): 640–6 (2006): 2mg/kg over 15 mins, followed by 3mg/kg/

Intra-operative lignocaine infusion. Replica of methodology from existing study, specifically Kuo et al, British Journal of Anaesthesia, 97 (5): 640–6 (2006): 2mg/kg over 15 mins, followed by 3mg/kg/hr IV. Continued intra-op and 30 mins post op. Intraoperative top-up fentanyl and post operative morphine patient controlled analgesia (PCA) if required. Additional resource [ANZCTR no: 12609001073291] & Annals of Surgery - Volume 246, Number 2, August 2007 page 192 - slight modification in methodology & dose


Locations(1)

New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611001005943